[
    {
        "molecule_name": "antibody",
        "protein_target_name": "human CD40",
        "binding_metric": "Kd",
        "value": "<10^−7",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human CD40, as the analyte and the antibody as the ligand, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\n* Accordingly, an antibody that “specifically binds to human CD40” refers to an antibody that binds to soluble or cell bound human CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower.\n* An antibody that “cross-reacts with cynomolgus CD40” refers to an antibody that binds to cynomolgus CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "human CD40",
        "binding_metric": "Kd",
        "value": "<10^−8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human CD40, as the analyte and the antibody as the ligand, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\n* Accordingly, an antibody that “specifically binds to human CD40” refers to an antibody that binds to soluble or cell bound human CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower.\n* An antibody that “cross-reacts with cynomolgus CD40” refers to an antibody that binds to cynomolgus CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "human CD40",
        "binding_metric": "Kd",
        "value": "10^−9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human CD40, as the analyte and the antibody as the ligand, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\n* Accordingly, an antibody that “specifically binds to human CD40” refers to an antibody that binds to soluble or cell bound human CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower.\n* An antibody that “cross-reacts with cynomolgus CD40” refers to an antibody that binds to cynomolgus CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "human CD40",
        "binding_metric": "Kd",
        "value": "10^−10",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human CD40, as the analyte and the antibody as the ligand, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\n* Accordingly, an antibody that “specifically binds to human CD40” refers to an antibody that binds to soluble or cell bound human CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower.\n* An antibody that “cross-reacts with cynomolgus CD40” refers to an antibody that binds to cynomolgus CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "cynomolgus CD40",
        "binding_metric": "Kd",
        "value": "<10^−7",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human CD40, as the analyte and the antibody as the ligand, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\n* Accordingly, an antibody that “specifically binds to human CD40” refers to an antibody that binds to soluble or cell bound human CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower.\n* An antibody that “cross-reacts with cynomolgus CD40” refers to an antibody that binds to cynomolgus CD40 with a K<sub>D </sub>of 10<sup>−7 </sup>M or less, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower."
    }
]